«

»

CMS is allowing Medicare Advantage plans to cross negotiate Part B and D drug prices

Starting in 2019, insurers may use step therapy to choose the least expensive drug first before moving on to another prescription.

Read the full post at News Feed
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive